1 results match your criteria: "Research-to-Practice Center of Pediatric Psychiatry and Neurology[Affiliation]"
[Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
Zh Nevrol Psikhiatr Im S S Korsakova
November 2018
Research-to-Practice Center of Pediatric Psychiatry and Neurology, Healthcare Department of Moscow City, Moscow, Russia.
Aim: To assess the safety and clinical and neurophysiological efficacy of xeomin in children with spastic equinus and equinovarus foot deformity in cerebral palsy.
Material And Methods: Sixty-four patients with spastic forms of cerebral palsy (levels I-IV on the GMFCS) were enrolled into this multi-center open-label comparative randomized trial. The patients were administered xeomin or botox once, each drug being administered to 32 patients.